Patient-friendly, non-technical summary of research papers

June 2026 Research Update

This report covers research on Sanfilippo syndrome published in PubMed in June 2026. For other months, see all research updates.

Last update: July 2, 2026

At a glance

NAGLU gene range

Many different NAGLU gene changes appeared in type B.

New NAGLU changes

Two NAGLU gene changes were first reported in one group.

Vision-led findings

HGSNAT changes were linked to vision loss without clear Sanfilippo.

Genes, not treatments

This month focused on genetics, with no new treatment studies found. Reports suggest Sanfilippo-related genes may be linked to a wider range of signs, though some links remain uncertain.

Overview

This month, the literature was mainly about genetics in Sanfilippo-related genes. There were no new treatment studies in the provided research.

One theme was variety in Sanfilippo type B (MPS IIIB). A group of 27 Brazilian patients had many different changes in the NAGLU gene. Two of these NAGLU changes were described for the first time in that report. The researchers also reported finding most of the expected disease-causing gene changes in this group, which supports that genetic confirmation was possible for many patients using their approach.

A second theme was that a Sanfilippo-related gene can sometimes show up with a different main health problem. A report described two people with retinitis pigmentosa, a progressive retina condition that affects vision, who had HGSNAT gene changes and low HGSNAT enzyme activity in blood. These two people did not have clear Sanfilippo syndrome, which suggests HGSNAT-related disease may sometimes mainly affect the eyes.

Overall, the month added to the picture that Sanfilippo-related genes can be linked to a wider range of signs than the classic childhood syndrome. Some details remain uncertain, such as whether HGSNAT changes are reliably linked to adult-onset hearing loss.

Get the monthly update by email

Subscribe here to receive an email when a new monthly Sanfilippo syndrome update is published. You can unsubscribe at any time. Your address is used for this only; delivery is handled by MailerLite (privacy policy).

Research topics this month

This month added to the idea that Sanfilippo syndrome is genetically diverse, and that some disease-related genes may show up in people who do not look like the classic childhood syndrome. Across these studies, researchers mapped many different gene variants in known Sanfilippo genes, and also described eye disease linked to a Sanfilippo-related gene even when other typical Sanfilippo features were not obvious. This matters because it suggests that the same gene can be connected to a wider range of signs than many families expect.

In 27 Brazilian patients with Sanfilippo type B (MPS IIIB), genetic testing found a wide mix of NAGLU variants, including 2 variants the authors described for the first time. The authors also reported that they identified 90.7% of the expected disease-causing alleles, which supports that most patients in this group could be genetically confirmed using the approaches used. Put simply, this study reinforces that there are many different genetic routes to MPS IIIB, and some may be unique or under-reported in specific populations.

A separate report described 2 people with retinitis pigmentosa (a progressive retina condition that affects vision) who had two HGSNAT gene variants each, plus clearly reduced HGSNAT enzyme activity in blood. The key point was that these patients did not have overt Sanfilippo syndrome, suggesting HGSNAT-related disease can sometimes mainly affect the eyes rather than causing the full multi-system picture people associate with Sanfilippo type C. One of the two patients also had hearing loss, but the authors noted more evidence is needed to firmly connect adult-onset hearing loss to HGSNAT variants.

For families living with Sanfilippo, these studies mainly add understanding rather than changing treatment today. The NAGLU study supports the reality that genetic results can vary widely from person to person and across regions, which can matter for getting a precise diagnosis and for future research that depends on knowing the exact variant. The HGSNAT report is early evidence from 2 people, but it helps clarify that Sanfilippo-related genes may sometimes be found in people whose main issue is vision loss, and the full set of Sanfilippo symptoms may not always be present. What remains uncertain is how often these non-classic presentations occur and how reliably they predict other health problems over time.

Limitations

No new treatment studies were included in this month’s input.
The HGSNAT and retinitis pigmentosa finding came from only two patients.
The possible link between HGSNAT changes and hearing loss remains uncertain.

Important information

This document summarizes recent research from PubMed-indexed publications using automated methods.
It is intended for educational purposes and does not replace medical advice.
Links to the original studies are provided via PubMed, where readers can explore abstracts and, when available, access full-text articles.
Some studies may include additional details that were not accessible for this summary.
Readers seeking more complete detail or context may find it helpful to review the original studies directly.